<DOC>
	<DOCNO>NCT00349830</DOCNO>
	<brief_summary>The purpose study measure level serum proteins biomarkers cancer patient patient suspected cancer . We believe marker may useful confirm diagnosis select patient specific type cancer therapy . These marker may also help predict response therapy , relapse therapy , survival therapy .</brief_summary>
	<brief_title>Novel Serum Markers Monitoring Response Anti-Cancer Therapy</brief_title>
	<detailed_description>This blood serum collection study Stanford University patient cancer variety disease sit . The purpose study collect store blood serum patient , , anti-cancer therapy find new biomarkers signal disease response anti-cancer therapy . The collection analysis biomarkers may lead improved diagnostic treatment therapy certain cancer future . We also interest collect blood serum healthy individual spouse , relative , friend cancer patient obtain healthy control comparison</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>1 . Age &gt; = 18 ; sample collect NIH grant , subject age 20 enrol . 2 . Prior diagnosis cancer suspect cancer 3 . Karnofsky performance status great 70 4 . Standard pretreatment evaluation 5 . Signed Stanford University Human Subjects Committee consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>